These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9545793)

  • 1. [Immune privilege of the eye].
    Grisanti S
    Ophthalmologe; 1998 Feb; 95(2):124-35. PubMed ID: 9545793
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune privilege in the anterior chamber of the eye.
    Niederkorn JY
    Crit Rev Immunol; 2002; 22(1):13-46. PubMed ID: 12186187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulators of immunological responses in the cornea and the anterior chamber of the eye.
    Jager MJ; Gregerson DS; Streilein JW
    Eye (Lond); 1995; 9 ( Pt 2)():241-6. PubMed ID: 7556725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anterior chamber-associated immune deviation, ocular immune privilege, and orthotopic corneal allografts.
    Streilein JW; Yamada J; Dana MR; Ksander BR
    Transplant Proc; 1999 May; 31(3):1472-5. PubMed ID: 10330973
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunological non-responsiveness and acquisition of tolerance in relation to immune privilege in the eye.
    Streilein JW
    Eye (Lond); 1995; 9 ( Pt 2)():236-40. PubMed ID: 7556724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma delta T cells are needed for ocular immune privilege and corneal graft survival.
    Skelsey ME; Mellon J; Niederkorn JY
    J Immunol; 2001 Apr; 166(7):4327-33. PubMed ID: 11254685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunology and immunomodulation of corneal transplantation.
    Niederkorn JY
    Int Rev Immunol; 2002; 21(2-3):173-96. PubMed ID: 12424842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation.
    Yamada J; Zhu SN; Streilein JW; Dana MR
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4203-8. PubMed ID: 11095616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Corneal Nerve Ablation on Immune Tolerance Induced by Corneal Allografts, Oral Immunization, or Anterior Chamber Injection of Antigens.
    Mo J; Neelam S; Mellon J; Brown JR; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):137-148. PubMed ID: 28114571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune privilege and immune regulation in the eye.
    Niederkorn JY
    Adv Immunol; 1990; 48():191-226. PubMed ID: 2190450
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of local macrophage depletion on cellular immunity and tolerance evoked by corneal allografts.
    Slegers TP; van der Gaag R; van Rooijen N; van Rij G; Streilein JW
    Curr Eye Res; 2003 Feb; 26(2):73-9. PubMed ID: 12815525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of anterior chamber-associated immune deviation by corneal allografts placed in the anterior chamber.
    Yamada J; Streilein JW
    Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2833-43. PubMed ID: 9418737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of ocular immune privilege in the year 2010: modifying the immune privilege of the eye.
    Hori J; Vega JL; Masli S
    Ocul Immunol Inflamm; 2010 Oct; 18(5):325-33. PubMed ID: 20849282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune privilege in corneal transplantation.
    Hori J; Yamaguchi T; Keino H; Hamrah P; Maruyama K
    Prog Retin Eye Res; 2019 Sep; 72():100758. PubMed ID: 31014973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of immunologic privilege within the anterior chamber of the eye.
    Kaplan HJ; Streilein JW
    Transplant Proc; 1977 Mar; 9(1):1193-5. PubMed ID: 325745
    [No Abstract]   [Full Text] [Related]  

  • 16. Latanoprost does not affect immune privilege of corneal allografts.
    Wang M; Kitahara Y; Yoshida A; Hori J
    Exp Eye Res; 2008 Feb; 86(2):394-402. PubMed ID: 18187130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of donor-specific ACAID can prolong orthotopic corneal allograft survival in "high-risk" eyes.
    Sano Y; Okamoto S; Streilein JW
    Curr Eye Res; 1997 Nov; 16(11):1171-4. PubMed ID: 9395779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive properties of tissues obtained from eyes with experimentally manipulated corneas.
    Streilein JW; Bradley D; Sano Y; Sonoda Y
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):413-24. PubMed ID: 8603847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunology of corneal transplantation.
    Niederkorn JY
    Dev Ophthalmol; 1999; 30():129-40. PubMed ID: 10627921
    [No Abstract]   [Full Text] [Related]  

  • 20. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2176-85. PubMed ID: 7558710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.